20 May 2013
Keywords: ganaxolone, effective, epilepsy, migraine, cocensys, reported, based
Article | 07 November 1997
CoCensys has reported that, based on encouraging Phase II findings, itwill proceed with further development of its lead epalon compound, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.